0001593968-22-000745.txt : 20220314 0001593968-22-000745.hdr.sgml : 20220314 20220314165327 ACCESSION NUMBER: 0001593968-22-000745 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220311 FILED AS OF DATE: 20220314 DATE AS OF CHANGE: 20220314 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Brockstedt Dirk G. CENTRAL INDEX KEY: 0001635616 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38997 FILM NUMBER: 22737301 MAIL ADDRESS: STREET 1: C/O ADURO BIOTECH, INC. STREET 2: 740 HEINZ AVENUE CITY: BERKELEY STATE: CA ZIP: 94710 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: RAPT Therapeutics, Inc. CENTRAL INDEX KEY: 0001673772 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 473313701 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 561 ECCLES AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: (650) 489-9000 MAIL ADDRESS: STREET 1: 561 ECCLES AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 FORMER COMPANY: FORMER CONFORMED NAME: FLX Bio, Inc. DATE OF NAME CHANGE: 20160504 4 1 primary_01.xml PRIMARY DOCUMENT X0306 4 2022-03-11 0001673772 RAPT Therapeutics, Inc. RAPT 0001635616 Brockstedt Dirk G. C/O RAPT THERAPEUTICS, INC., 561 ECCLES AVENUE SOUTH SAN FRANCISCO CA 94080 false true false false Chief Scientific Officer Common Stock 2022-03-11 4 M false 2648 6.18 A 22460 D Common Stock 2022-03-11 4 S false 2648 23.91 D 19812 D Option (right to buy) 6.18 2022-03-11 4 M false 2648 0 D 2028-03-27 Common Stock 2648 17047 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Reporting Person. Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in 36 equal monthly installments thereafter for the following three years. /s/ Rodney Young, Attorney-in-Fact for Dirk G Brockstedt 2022-03-14